Picture of Cassie Wannan

Are memory impairments in early and chronic schizophrenia related to the volume of particular hippocampal subfields?

Insights Back to resource centre 17 September 2019 Are memory impairments in early and chronic schizophrenia related to the volume of particular hippocampal subfields? Cassandra Wannan, final year PhD student at the University of Melbourne, shared the role that CANTAB played in her latest publication: Hippocampal subfields and visuospatial associative memory across stages of schizophrenia-spectrum disorder. Can you tell us

Are memory impairments in early and chronic schizophrenia related to the volume of particular hippocampal subfields? Read More »

What is the value of including cognitive assessments in the quantification of vascular and neuronal pathology in dementia using PET and MRI?

Insights Back to resource centre 3 September 2019 What is the value of including cognitive assessments in the quantification of vascular and neuronal pathology in dementia using PET and MRI? We caught up with researchers from the Division of Neuroscience and Experimental Psychology, University of Manchester to discuss the role that CANTAB plays in their cutting-edge neuroimaging study. Can you

What is the value of including cognitive assessments in the quantification of vascular and neuronal pathology in dementia using PET and MRI? Read More »

Why does the largest twins registry in the UK use CANTAB?

Insights Back to resource centre 13 August 2019 Why does the largest twins registry in the UK use CANTAB? TwinsUK has been using CANTAB for the last 10 years to enable their multi-modal, longitudinal research into typical and pathological ageing. We caught up with the Project Coordinator, Taha Bhatti, to discuss the cohort’s experience of completing the tasks, and transitioning

Why does the largest twins registry in the UK use CANTAB? Read More »

Cognitive Safety: Satisfying Regulatory Requirements in a Competitive Landscape

Webinars Back to resource centre 11 January 2023 Cognitive Safety: Satisfying Regulatory Requirements in a Competitive Landscape Common disease states, environmental toxins, certain medications and the aging process itself can all compromise the integrity of the BBB. Accordingly, both central nervous system (CNS) and non-CNS therapeutics (e.g. for cardiovascular disease, diabetes, cancer, pain) can present significant challenges for cognitive safety

Cognitive Safety: Satisfying Regulatory Requirements in a Competitive Landscape Read More »

Could colour blindness be affecting the results of your study?

Insights Back to resource centre 28 May 2019 Could colour blindness be affecting the results of your study? With colour vision deficiency affecting an estimated 300 million people worldwide, we consider how colour blindness might affect participants’ performance on cognitive tests, and what measures can be taken to minimise the impact on study results. What is colour blindness?Colour blindness, or

Could colour blindness be affecting the results of your study? Read More »

NHS Bedfordshire CCG rolls out CANTAB Mobile to 50 practices following successful pilot study

News Back to resource centre 24 May 2019 NHS Bedfordshire CCG rolls out CANTAB Mobile to 50 practices following successful pilot study We’re pleased to announce that NHS Bedfordshire Clinical Commissioning Group (CCG) is introducing our iPad-based memory assessment tool into 50 general practices.We’re pleased to announce that NHS Bedfordshire Clinical Commissioning Group (CCG) is introducing CANTAB Mobile, our iPad-based

NHS Bedfordshire CCG rolls out CANTAB Mobile to 50 practices following successful pilot study Read More »

Picture of Arvin

Does neuregulin 1 affect executive function in autism spectrum disorder?

Insights Back to resource centre 14 January 2019 Does neuregulin 1 affect executive function in autism spectrum disorder? We caught up with Dr Arvin Haghighatfard to discuss why he chose CANTAB to investigate the effects of neuregulin 1 on executive dysfunction in autism spectrum disorder. Can you tell us more about yourself and your research group?I am Arvin Haghighatfard, geneticist;

Does neuregulin 1 affect executive function in autism spectrum disorder? Read More »

Picture of Beatrice Powell

6 tests for assessing cognition in Parkinson’s disease

Insights Back to resource centre 18 December 2018 6 tests for assessing cognition in Parkinson’s disease Cognitive dysfunction in Parkinson’s disease remains a significant, unmet therapeutic need for patients; as such it is vital that there is rigorous research into the topic. Here we will discuss six CANTAB tasks that can address this research gap. Parkinson’s disease is a complex

6 tests for assessing cognition in Parkinson’s disease Read More »

Scroll to Top